Lawrence Jasinski Biography and Net Worth

Director of LeMaitre Vascular

Lawrence J. Jasinski has served as a member of our Board of Directors since 2003. Mr. Jasinski is the Chief Executive Officer of ReWalk Robotics Ltd. (formerly Argo Medical Technologies), a NASDAQ–listed company that has created and commercialized the first Exoskeleton Technology, which enables paralyzed individuals the ability to walk again. He has also served on the Board of Directors of ReWalk Robotics since 2012. From 2005 until 2012, he was President and Chief Executive Officer of Soteira, Inc., a company that offered products which treated individuals with vertebral compression fractures. From 2000 to 2005, he was President and Chief Executive Officer of Cortek, Inc., a company that developed next-generation treatments for degenerative disc disease. From 1985 to 2000, Mr. Jasinski worked at Boston Scientific Corporation (“BSC”) and served as its Vice President of Global Marketing, BSC Vascular, from 1998 to 2000. Mr. Jasinski received a B.S. in Marketing from Providence College and an M.B.A. from the University of Bridgeport. Mr. Jasinski is also a member of the Board of Directors for Massachusetts Bay Lines, a company that offers commuter services and other commercial vessel services in the Boston Harbor and Islands. The Board has concluded that Mr. Jasinski should serve on our Board due to his experience serving in a variety of executive level positions, coupled with his more than 20 years of experience in the medical device industry, which provides the Board with an understanding of the current trends as well as provides us with deeper contacts in the industry. Mr. Jasinski also provides the Board with operational experience, including building and organizing an effective sales force, seeking and obtaining regulatory approvals for medical devices, and managing significant manufacturing operations.

What is Lawrence J. Jasinski's net worth?: The estimated net worth of Lawrence J. Jasinski is at least $9.22 million as of September 13th, 2024. Mr. Jasinski owns 100,637 shares of LeMaitre Vascular stock worth more than $9,219,356 as of April 26th. This net worth approximation does not reflect any other assets that Mr. Jasinski may own. Learn More about Lawrence J. Jasinski's net worth.
How do I contact Lawrence J. Jasinski?: The corporate mailing address for Mr. Jasinski and other LeMaitre Vascular executives is 63 SECOND AVENUE, BURLINGTON MA, 01803. LeMaitre Vascular can also be reached via phone at (781) 221-2266. Learn More on Lawrence J. Jasinski's contact information.
Has Lawrence J. Jasinski been buying or selling shares of LeMaitre Vascular?: Lawrence J. Jasinski has not been actively trading shares of LeMaitre Vascular within the last three months. Most recently, Lawrence J. Jasinski sold 5,110 shares of the business's stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $67.50, for a transaction totalling $344,925.00. Following the completion of the sale, the director now directly owns 5,309 shares of the company's stock, valued at $358,357.50. Learn More on Lawrence J. Jasinski's trading history.
Who are LeMaitre Vascular's active insiders?: LeMaitre Vascular's insider roster includes Lawrence Jasinski (Director), Trent Kamke (Senior Vice President, Operations), George Lemaitre (Chairman & CEO), Joseph Pellegrino, Jr. (CFO), David Roberts (Director), Bridget Ross (Director), and John Roush (Director). Learn More on LeMaitre Vascular's active insiders.
Are insiders buying or selling shares of LeMaitre Vascular?: In the last twelve months, insiders at the medical instruments supplier sold shares 10 times. They sold a total of 136,441 shares worth more than $10,888,005.35. The most recent insider tranaction occured on March, 12th when insider Trent G Kamke sold 2,009 shares worth more than $164,979.08. Insiders at LeMaitre Vascular own 10.8% of the company. Learn More about insider trades at LeMaitre Vascular.
Information on this page was last updated on 3/12/2025.

Lawrence J. Jasinski Insider Trading History at LeMaitre Vascular

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2024	Sell	5,110	$67.50	$344,925.00	5,309
3/2/2023	Sell	192	$50.00	$9,600.00	9,310
3/1/2021	Sell	7,500	$51.28	$384,600.00	10,833
11/24/2020	Sell	7,500	$39.50	$296,250.00	13,333
8/6/2019	Sell	5,000	$32.00	$160,000.00	10,833
8/17/2017	Sell	2,030	$34.23	$69,486.90	8,333
8/1/2017	Sell	6,500	$34.47	$224,055.00	12,863
8/9/2016	Sell	7,500	$17.60	$132,000.00	12,863
6/3/2016	Sell	4,924	$14.99	$73,810.76	12,787
5/25/2016	Sell	6,326	$15.30	$96,787.80	15,642
11/16/2015	Sell	7,500	$13.57	$101,775.00	14,113
9/4/2014	Sell	3,750	$7.14	$26,775.00

Lawrence J. Jasinski Buying and Selling Activity at LeMaitre Vascular

LeMaitre Vascular Company Overview

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Today's Range

Now: $91.61

$90.23

$92.05

50 Day Range

MA: $86.90

$77.89

$104.00

2 Week Range

Now: $91.61

$64.27

$109.58

Volume

106,920 shs

Average Volume

161,598 shs

Market Capitalization

$2.07 billion

P/E Ratio

50.06

Dividend Yield

0.87%

Beta

0.89